Borella
Alessandro Borella, Stra IT
Christopher Borella, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20130142831 | COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES - The invention relates to compounds of formula (I): | 06-06-2013 |
Christopher Borella, Bedford, MA US
Patent application number | Description | Published |
---|---|---|
20090270353 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 10-29-2009 |
20100093670 | Compounds for the treatment of angiogenesis - The invention relates to isoxazole, isothiazole, and triazole compounds that are useful for treating or inhibiting angiogenesis. | 04-15-2010 |
20100279410 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 11-04-2010 |
20110059893 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 03-10-2011 |
20120022118 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 01-26-2012 |
20120040937 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 02-16-2012 |
20120065206 | COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS - The present invention is directed to compounds represented by structural formula (I), or a pharmaceutically acceptable salt or a transition metal chelate, coordinate or complex thereof or a transition metal chelate, coordinate or complex of a deprotonated form of the compound. Pharmaceutical composition and method of use for these compounds are also included. | 03-15-2012 |
20120214824 | PROTEOSTASIS REGULATORS - The present invention is directed to compounds of Formulae (I), (II), (III), (IV), (V), (VI), (VII), and (VIII), pharmaceutical compositions thereof and methods of use thereof in the treatment of conditions associated with a dysfunction in proteostasis. | 08-23-2012 |
20120289483 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 11-15-2012 |
20130203824 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 08-08-2013 |
20130338112 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 12-19-2013 |
20140045795 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The invention relates to compounds of structural formula (I): | 02-13-2014 |
Fabio Borella, Milano IT
Patent application number | Description | Published |
---|---|---|
20130310329 | COMBINED THERAPY FOR CYSTIC FIBROSIS - There is disclosed a combination of inhibitors of Tissue Transglutaminase (TG2), inhibitors of reactive oxygen species (ROS) and CFTR channel activators (potentiators) for separate, sequential or simultaneous administration to CF patients carrying the ΔF508-CFTR mutation, and pharmaceutical compositions thereof. | 11-21-2013 |
Mathias Borella, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20080220525 | CULTURE SUBSTRATE PROVIDED WITH AN OXIDISED SILICONE COATING - Solid culture substrate comprising, on at least one of its surfaces, a coating made of a material chosen from the oxidised silicones, said coating comprising a nanostructuration and/or a surface nanoroughness, and a surface nanoporosity. | 09-11-2008 |
20090081384 | Low Wetting Hysteresis Polysiloxane-Based Material and Method for Depositing Same - A polysiloxane-based material presents a predetermined structure or conformation such that the polysiloxane-based material comprises a ratio between a number of linear —Si—O— bonds and a number of cyclic —Si—O— bonds less than or equal to 0.4, and preferably less than or equal to 0.3. Such a polysiloxane-based material enables a wetting hysteresis less than 10°, and preferably less than 5° to be obtained. Such a low wetting hysteresis material can be achieved by chemical vapor deposition enhanced by a plasma wherein a precursor is injected. The precursor is selected from the group consisting of cyclic organosiloxanes such as octamethylcyclotetrasiloxane and derivatives thereof and cyclic organosilazanes such as octamethylcyclosilazane and derivatives thereof. A ratio between a power density dissipated in the plasma and a precursor flow rate injected in the plasma is less than or equal to 100 W.cm | 03-26-2009 |
Michael S. Borella, Naperville, IL US
Patent application number | Description | Published |
---|---|---|
20100272121 | SYSTEM AND METHOD FOR ROAMING BETWEEN WIRELESS NETWORKS - Systems and methods for roaming between a mobile node and at least one serving node connected to a network are disclosed. The present application provides a method for roaming between. In the system and method, a first communication is established between the mobile node and one of the serving nodes through a control server, when an Ethernet transceiver is used by the mobile node. Ethernet is used for communications between the mobile node and the control server, and a wireless communication technology for communications between the control server and the serving node. The control server also translates communications between Ethernet and the wireless communication technology. In the system and method, a second communication is established between the mobile node and one of the serving nodes with the wireless communication technology, when a wireless communication technology transceiver is used by the mobile node. | 10-28-2010 |
20120093142 | SYSTEM AND METHOD FOR ROAMING BETWEEN WIRELESS NETWORKS - Systems and methods for roaming between a mobile node and at least one serving node connected to a network are disclosed. The present application provides a method for roaming between. In the system and method, a first communication is established between the mobile node and one of the serving nodes through a control server, when an Ethernet transceiver is used by the mobile node. Ethernet is used for communications between the mobile node and the control server, and a wireless communication technology for communications between the control server and the serving node. The control server also translates communications between Ethernet and the wireless communication technology. In the system and method, a second communication is established between the mobile node and one of the serving nodes with the wireless communication technology, when a wireless communication technology transceiver is used by the mobile node. | 04-19-2012 |
Ricco B. Borella, Zuerich CH
Patent application number | Description | Published |
---|---|---|
20130143977 | Ethylene Oxide/Propylene Oxide Polyether Polyols and Polyurethanes Made Therefrom - Copolymers of propylene oxide and ethylene oxide have an inner block that contains from 65-90 weight percent oxyethylene units and from 10 to 35 weight percent oxypropylene units. This block has a molecular weight of from 150 to 350. The copolymer has an outer block which contains at least 95 weight % oxypropylene units and from 0 to 5% oxyethylene units. The equivalent weight of the copolymer is from 800 to 2000. The copolymers are useful in making polyurethane foams that have unexpectedly high tensile and/or tear strengths. | 06-06-2013 |
Ricco B. Borella, Schindellegi CH
Patent application number | Description | Published |
---|---|---|
20140051778 | FINE PARTICLE, HIGH CONCENTRATION, POLYISOCYANATE POLYADDITION/POLYURETHANE-UREA POLYOLS - Embodiments of the invention include a method of producing polymer polyol dispersions is. The method includes providing at least one reaction system, and the reaction system includes: a) at least one polyol, b) at least one seed population, c) at least one catalyst, d) at least one co-reactant having an equivalent weight of up to 400 and at least one active hydrogen attached to a nitrogen or oxygen atom, and e) at least one polyisocyanate. The at least one seed population includes less than about 5% by weight of the total weight of the at least one reaction system and includes seed particles having diameters of less than 5 μm. The at least one reaction mixture reacts to form at least one of a polyurea and polyurethane-urea particle population in the at least one polyol without the addition of any catalysts comprising tin. The polymer polyol dispersion has a solids content of at least 15% of the weight of the polymer polyol dispersion. | 02-20-2014 |
20140163197 | PROCESS FOR MAKING POLYETHER ALCOHOLS HAVING OXYETHYLENE UNITS BY POLYMERIZATION OF ETHYLENE CARBONATE IN THE PRESENCE OF DOUBLE METAL CYANIDE CATALYSTS - Ethylene carbonate is polymerized by itself or together with another cyclic monomer such as 1,2-propylene oxide in the presence of a double metal cyanide catalyst. Most of the ethylene carbonate adds to the chain to form a terminal carbonate group, which decarboxylates to produce a hydroxyethyl group at the end of the polymer chain. The polymerization of more ethylene carbonate onto the chain end results in the formation of poly(ethyleneoxy) units. Therefore, the process provides a method for making poly(ethyleneoxy) polymers without the need to polymerize ethylene oxide. The process is useful for making polyethers that are useful as water-absorbable polymers, surfactants and as raw materials for polyurethanes. The process is also useful for increasing the primary hydroxyl content of a polyether. | 06-12-2014 |
20150038653 | TIN FREE POLYMER POLYOLS - Embodiments include polymer polyol dispersions which include a polyol liquid phase and solid particle phase. Embodiments include methods of making the polymer polyol dispersions. The polymer polyol dispersions are essentially free of tin, have a solid content of between about 20 and 50 wt % based on the total weight of the polymer polyol dispersion, and have a viscosity at 20C of less than 9000 mPas. The solid particle phase has more than 90% by weight of particles in the solid particle phase having a particle diameter of less than 5 μm. | 02-05-2015 |
Scott Borella, Charlotte, NC US
Patent application number | Description | Published |
---|---|---|
20100137262 | Low Calcemic, Highly Antiproliferative, Analogs of Calcitriol - The disclosure provides compounds, compositions and methods using these compounds and compositions to stimulate the differentiation of cells and inhibit excessive cell proliferation of certain cells, including cancer cells and skin cells, which may be useful in the treatment of diseases characterized by abnormal cell proliferation and/or cell differentiation such as leukemia, myelofibrosis and psoriasis without the well known effect on calcium metabolism, which gives rise to hypercalcemia. | 06-03-2010 |